Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (651-660 of 1,058) with videos related to

Pageof 106
Sort By:
American Journal of Health Promotion : AJHP|September 16, 2016
Path Analysis of Campus Walkability/Bikeability and College Students' Physical Activity Attitudes, Behaviors, and Body Mass IndexTanya M Horacek, E Dede Yildirim, K Kattelmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020
Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic LeukemiaShanmugapriya Thangavadivel, Qiuhong Zhao, Narendranath Epperla, et al.
Leukemia|January 21, 2012
Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapseE Braggio, N E Kay, S VanWier, et al.
Leukemia|October 23, 2009
Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemiaA Sanchez-Aguilera, I Rattmann, D Z Drew, et al.
Leukemia & Lymphoma|October 29, 2009
A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemiaThomas S Lin, Wendy Stock, Huiping Xu, et al.
Blood Advances|January 4, 2018
Novel <i>SF3B1</i> in-frame deletions result in aberrant RNA splicing in CLL patientsAnant A Agrawal, Michael Seiler, Lindsey T Brinton, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemiaVeronica Balatti, Lara Rizzotto, Cecelia Miller, et al.
Molecular Cancer Therapeutics|June 6, 2019
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid LeukemiaDimitrios Papaioannou, Deedra Nicolet, Hatice G Ozer, et al.
The AAPS Journal|September 8, 2012
Pharmacokinetics and tissue disposition of lenalidomide in miceDarlene M Rozewski, Sarah E M Herman, William H Towns, et al.
American Journal of Hematology|August 21, 2013
Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkin's lymphomaJeffrey A Jones, Amy S Rupert, Ming Poi, et al.
Pageof 106

Showing results (651-660 of 1,058) with videos related to

Sort By:
Pageof 106
American Journal of Health Promotion : AJHP|September 16, 2016
Path Analysis of Campus Walkability/Bikeability and College Students' Physical Activity Attitudes, Behaviors, and Body Mass IndexTanya M Horacek, E Dede Yildirim, K Kattelmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020
Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic LeukemiaShanmugapriya Thangavadivel, Qiuhong Zhao, Narendranath Epperla, et al.
Leukemia|January 21, 2012
Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapseE Braggio, N E Kay, S VanWier, et al.
Leukemia|October 23, 2009
Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemiaA Sanchez-Aguilera, I Rattmann, D Z Drew, et al.
Leukemia & Lymphoma|October 29, 2009
A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemiaThomas S Lin, Wendy Stock, Huiping Xu, et al.
Blood Advances|January 4, 2018
Novel <i>SF3B1</i> in-frame deletions result in aberrant RNA splicing in CLL patientsAnant A Agrawal, Michael Seiler, Lindsey T Brinton, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemiaVeronica Balatti, Lara Rizzotto, Cecelia Miller, et al.
Molecular Cancer Therapeutics|June 6, 2019
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid LeukemiaDimitrios Papaioannou, Deedra Nicolet, Hatice G Ozer, et al.
The AAPS Journal|September 8, 2012
Pharmacokinetics and tissue disposition of lenalidomide in miceDarlene M Rozewski, Sarah E M Herman, William H Towns, et al.
American Journal of Hematology|August 21, 2013
Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkin's lymphomaJeffrey A Jones, Amy S Rupert, Ming Poi, et al.
Pageof 106